Table 5 Serum PTH Concentrations in HRG patients on Alfaclacidol Versus HRG patients not on alfacalcidol
From: A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis
HRG | Visit 2 | Visit 10 | Visit 13 | Visit 16 | Visit 19 |
|---|---|---|---|---|---|
Yes - Alfacalcidol | |||||
25% Percentile | 341 | 276 | 271.7 | 175.4 | 214.1 |
Median | 512.5 | 416 | 429.7 | 474.3 | 512 |
75% Percentile | 827.5 | 676 | 693.2 | 752.6 | 842.1 |
No - Alfacalcidol | |||||
25% Percentile | 67 | 77 | 39 | 90 | 108 |
Median | 290 | 229 | 237 | 262 | 250 |
75% Percentile | 435 | 426 | 433 | 515 | 486 |
P-value | 0.007 | 0.05 | 0.07 | 0.16 | 0.1 |